期刊文献+

NK细胞活化受体及配体在急性白血病患者外周血中的表达和脱离 被引量:4

Expression and Abscission of Activated Receptors and Their Ligands on/from NK Cells in Peripheral Blood of Patients with Acute Leukemia
下载PDF
导出
摘要 本研究旨在从NK细胞活化性受体NKG2D及其相应配体——MICA/B、ULBP-1、2、3的表达和血清中脱离情况来探讨急性白血病患者NK细胞免疫防御功能损伤的可能机制。选择30例初发未治疗的急性白血病患者作为观察对象,10例健康者作为对照,应用流式细胞术检测白血病细胞表面MICA/B,ULBP-1、2、3表达水平,用ELISA法检测血清可溶性MICA、MICB(sMICA,sMICB)及可溶性ULBP1-3(sULBP1-3)水平。结果表明,急性白血病患者NK细胞NKG2D的表达低于正常对照组;急性白血病患者白血病细胞表面不表达或弱表达MICA/B、ULBP1-3;急性白血病患者血清中游离的sMICA和sMICB水平均高于对照组,差异有统计学意义(p<0.01),血清sULBP1-3水平与对照组无明显差异。结论:急性白血病细胞表面MICA和MICB的脱离及ULBP表达缺乏可能是急性白血病细胞发生免疫逃逸的机制之一。 This study was aimed to explore the immune escaping mechanisms based on expression and abscission of human natural killer (NK) cell activating receptors NKG2D and their ligands MICA/B, ULBP-1,2,3 in patients with acute leukemia (AL). 30 de novo AL patients and 10 healthy persons (control) were enrolled in study. Flow cytometry was used to detect the expression levels of MICA/B, ULBP-1,2,3 on leukemic cells. ELISA was used to detect the levels of soluble MICA (sMICA), solube MICB (sMICB) and soluble ULBP-1 ,-2,-3 in the serum. The results showed that sMICA, sMICB and ULBP-1 ,-2 ,-3 were not expressed or expressed at very low levels on leukemia cells of the patients; the levels of free sMICA and sMICB in serum of AL patients were higher than that in serum of healthy persons, there was significant difference (p 〈0.01). But the levels of ULBP 1 -3 in serum of AL patients did not show obvious statistical difference as compared with healthy persons (p 〉 0.05 ). It is concluded that the negative or low expression of NKG2D ligands (MICA, MICB and ULBPs) on surface of acute leukemia cells may lead to the immune escape of leukemia cells, the abscission of MICA and MICB, and the deficiency of ULBP expression on leukemia cells may be one of immune escape mechanisms of leukemia cells.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第2期436-440,共5页 Journal of Experimental Hematology
基金 安徽省教育厅自然科学研究项目(编号2006KJ317B) 安徽省高校省级自然科学研究项目(编号KJ2008A17ZC)
关键词 NK细胞 MICA MICB ULBP 急性白血病 免疫逃逸 NK cell MICA MICB ULBP acute leukemia immune escape
  • 相关文献

参考文献13

  • 1Verheyden S, Bemier M, Demanet C. Identification of natural killer cell receptor phenotypes associated with leukemia. Leukemia, 2004; 18(12) : 2002 -2007.
  • 2Verheyden S, Demanet C. Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions. Leukemia,2006 ; 20 ( 8 ) : 1437 - 1438.
  • 3Pende D, Spaggiari GM, Marcenaro S, et al. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor ( CD155 ) and Nectin-2 ( CD112 ). Blood, 2005 ; 105 (5) : 2066 - 2073.
  • 4Diefenbach A, Jensen ER, Jamieson AM, et al. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature, 2001 ;413 ( 6852 ) : 165 - 171.
  • 5Epling-Burnette PK, Bai F, Painter JS, et al.Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood, 2007 ; 109 ( 11 ) : 4816 - 4824.
  • 6Song H, Hur DY, Kim KE, et al. IL-2/IL-18 prevent the downmodulation of NKG2D by TGF-beta in NK cells via the c-Jun N- terminal kinase (JNK) pathway. Cell Immunol,2006 ; 242( 1 ) : 39 -45.
  • 7Rohner A, Langenkamp U, Siegler U, et al. Differentiation- promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. Leuk Res, 2007 ;31 (10) : 1393 - 1402.
  • 8Farag SS, George SL, Lee El, et al. Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B Study 9420. Clin Cancer Res, 2002 ;8 (9) : 2812 - 2819.
  • 9Pende D, Rivera P, Marcenaro S, et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res, 2002 ;62 (21) :6178 - 6186.
  • 10Diermayr S, Himmelreich H, Durovic B, et al. NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities. Blood, 2008;111 (3) : 1428 - 1436.

同被引文献55

  • 1邹勇,宁琴(审校).NK细胞受体与配体的特异识别[J].国际免疫学杂志,2007,30(3):194-198. 被引量:3
  • 2郑为东.活化性受体NKG2D及其配体的研究进展[J].国际免疫学杂志,2007,30(4):262-265. 被引量:1
  • 3Anfossi N, Andr P, Guia S, et al. Human NK cell education by inhibitory receptors for MHC class I [ J ]. Immunity, 2006, 25 (2) : 331-342.
  • 4Benitez AC, Dai Z, Mann HH, et al. Expression, signaling profi- ciency, and stimulatory function of the NKG2D lymphocyte recep- tor in human cancer cells [ J]. Nat Aca Sci, 2011, 108 (10) : 4081.
  • 5Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA [ J]. Science, 1999, 285(5428): 727-729.
  • 6Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICB in ma- lignant diseases : Analysis of diagnostic significance and correlation with soluble MICA [J].Cancer Immunol Immunotber, 2006, 55 (12) : 1584-1589.
  • 7Jonjic S, Babic M, Polic B, et al. Immune evasion of natural killer cells by viruses [J]. Curr Opin Immunol, 2008, 20(1) : 30-38.
  • 8Hanaoka N, Jabri B, Dai Z, et al. NKG2D initiates caspase-me- diated CD3 degradation and lymphocyte receptor impairments as- sociated with human cancer and autolmmune disease [ J ]. J Immu- nol, 2010, 185(10): 5732-5742.
  • 9Guerra N, Tan YX, Joneker NT, et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy [J]. Immunityol, 2008, 28(4): 571-580.
  • 10Morgado S, Sanchez-Correa B, Casado JG, et al. NK cell recogni- tion and killing of melanoma cells is controlled by multiple activa- ting receptor-ligand interactions [J]. J Inn Immunol, 2011, 3 (4) : 365-373.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部